Kantar Health

Global Population Health Management Market 2022 to 2031 - Featuring Allscripts Healthcare, Arcadia, Athenahealth and Citra Health Solutions Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 17, 2023

This report provides strategists, marketers and senior management with the critical information they need to assess the global population health management market.

Key Points: 
  • This report provides strategists, marketers and senior management with the critical information they need to assess the global population health management market.
  • The population health management market consists of sales of population health management solutions and related services by entities (organizations, sole proprietors, and partnerships) used to improve the health outcomes of a group by identifying and monitoring patients.
  • Major companies operating in population health management are looking for new product development to strengthen their position in the population health management market.
  • For instance, in October 2021, Verana Health, a US-based clinical database provider operating in the population health management market, launched VeraQ, a population health data engine.

Aetion Expands Executive Team with Three New Leaders

Retrieved on: 
Tuesday, November 8, 2022

NEW YORK, Nov. 8, 2022 /PRNewswire/ -- Aetion, the global leader in real-world evidence (RWE) technology and analytics, today announced the appointments of Professor Dorothee Bartels as Chief Digital Officer, Jade Cusick as Chief Commercial Officer, and Jeremy Brody as Chief Strategy Officer. Together, they will accelerate Aetion's momentum in serving life sciences, regulator and payer customers in the United States and Europe.

Key Points: 
  • Together, they will accelerate Aetion's momentum in serving life sciences, regulator and payer customers in the United States and Europe.
  • "At this pivotal time of increasing demand for real-world evidence, Dorothee, Jade and Jeremy bring unparalleled health care expertise and business acumen to Aetion's leadership team," said Carolyn Magill, Aetion CEO and Board Director.
  • "Their track records demonstrate a passion for using data and analytics to unite stakeholders in improving health outcomes for patients."
  • Aetion is a healthcare analytics company that delivers real-world evidence for the manufacturers, purchasers and regulators of medical treatments and technologies.

Aetion Expands Executive Team with Three New Leaders

Retrieved on: 
Tuesday, November 8, 2022

NEW YORK, Nov. 8, 2022 /PRNewswire/ -- Aetion, the global leader in real-world evidence (RWE) technology and analytics, today announced the appointments of Professor Dorothee Bartels as Chief Digital Officer, Jade Cusick as Chief Commercial Officer, and Jeremy Brody as Chief Strategy Officer. Together, they will accelerate Aetion's momentum in serving life sciences, regulator and payer customers in the United States and Europe.

Key Points: 
  • Together, they will accelerate Aetion's momentum in serving life sciences, regulator and payer customers in the United States and Europe.
  • "At this pivotal time of increasing demand for real-world evidence, Dorothee, Jade and Jeremy bring unparalleled health care expertise and business acumen to Aetion's leadership team," said Carolyn Magill, Aetion CEO and Board Director.
  • "Their track records demonstrate a passion for using data and analytics to unite stakeholders in improving health outcomes for patients."
  • Aetion is a healthcare analytics company that delivers real-world evidence for the manufacturers, purchasers and regulators of medical treatments and technologies.

Komodo Health Platform Accelerates Real-World Evidence For Life Sciences

Retrieved on: 
Monday, May 16, 2022

Today at the 2022 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) global conference, Komodo Health showcased how its technology platform is powering the next generation of real-world evidence (RWE) research.

Key Points: 
  • Today at the 2022 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) global conference, Komodo Health showcased how its technology platform is powering the next generation of real-world evidence (RWE) research.
  • In several new studies published at ISPOR, Komodo Health customers like Veradigm, Cerner, Trinity Life Sciences, and Pfizer have published studies powered by Komodos platform to advance the industrys understanding of patient experiences and treatment patterns.
  • For example:
    Veradigm Life Sciences and Madrigal Pharma explored the epidemiology of NASH using linked data sources to better understand the association between CVD risk and fibrosis stages for NASH patients.
  • Real-world evidence is foundational for generating information about the risks, benefits, and costs of different treatment options available in a therapeutic area, said Aswin Chandrakantan, MD, Chief Medical Officer at Komodo Health.

VistaGen and AffaMed Complete Key Regulatory Submissions for PALISADE Global Phase 3 Clinical Trial for PH94B

Retrieved on: 
Tuesday, April 12, 2022

NMPAs clearance to begin the PALISADE Global Phase 3 trial is a tremendous milestone in advancing our product portfolio targeting neurological and psychiatric indications.

Key Points: 
  • NMPAs clearance to begin the PALISADE Global Phase 3 trial is a tremendous milestone in advancing our product portfolio targeting neurological and psychiatric indications.
  • We thank the NMPA for recognizing the importance of this Phase 3 study and rapidly expediting the approval of our CTA.
  • VistaGen and AffaMed plan to begin enrolling participants in PALISADE Global during the second half of 2022, with topline results anticipated in mid-2024.
  • Separate from PALISADE Global, VistaGen is currently evaluating PH94B in Phase 3 clinical studies and a long-term safety study that, if successful, will support VistaGens PH94B NDA submission to the FDA.

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes

Retrieved on: 
Tuesday, October 26, 2021

The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, development and deployment of therapies and advance clinical research and the life sciences industry to improve everyday health.

Key Points: 
  • The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, development and deployment of therapies and advance clinical research and the life sciences industry to improve everyday health.
  • Cerner Enviza was established to unlock the power of data and a network of research-ready health systems to help get therapies to patients more quickly and at less expense.
  • With Cerner Enviza, we bring together the expertise, assets and capabilities of Kantar Health with Cerners technology and access to a large collection of deidentified patient health data, said Mike Kelly, Global Head of Cerner Enviza.
  • Cerner Enviza aims to accelerate the discovery, development and delivery of extraordinary insights and therapies to improve everyday health for people globally.By combining decades of innovation, life sciences knowledge and collaborative research, Cerner Enviza provides data-driven solutions and expertise that helps bring remarkable clarity to healthcares most important decisions.

AI Integration in Electronic Medical Records (EMR) to Push Growth at 7.8% CAGR through 2031: Future Market Insights finds in Latest Survey

Retrieved on: 
Thursday, August 12, 2021

These developments also will help in growth of the electronic medical records market during the forecast period.

Key Points: 
  • These developments also will help in growth of the electronic medical records market during the forecast period.
  • The electronic medical records market in India is expected to witness substantial growth as leading players collaborate to make deeper inroads.
  • Integration of healthcare IT and technologies such as artificial intelligence is expected to boost sales of electronic medical records.
  • Increasing installation of electronic medical records in specialized clinics for result management, decision support, and clinical trials will fuel the demand for electronic medical records.

AI Integration in Electronic Medical Records (EMR) to Push Growth at 7.8% CAGR through 2031: Future Market Insights finds in Latest Survey

Retrieved on: 
Thursday, August 12, 2021

DUBAI, UAE, Aug. 12, 2021 /PRNewswire/ -- According to a study by FMI, the global electronic medical records market is expected to register a CAGR of 7.8% during the forecast period between 2021 and 2031. The market is expected to reach a valuation of US$ 21.5 bn by the end of 2021.

Key Points: 
  • - The electronic medical records (EMR) market report offers insights into chief growth drivers and restrains impacting the overall growth trajectory.
  • The survey also provides insights into competitive landscape of global electronic medical records (EMR) market, identifying the key market players and analyzing the impact of their growth strategies.
  • These developments also will help in growth of the electronic medical records market during the forecast period.
  • Increasing installation of electronic medical records in specialized clinics for result management, decision support, and clinical trials will fuel the demand for electronic medical records.

PharmaVOICE Recognizes Kantar Health’s Jade Cusick as one of 100 Most Inspiring Leaders in Life Sciences

Retrieved on: 
Tuesday, August 3, 2021

Kantar Health, a leader in research, data and consulting for the life sciences industry and recently acquired by the Cerner Corporation on April 1, 2021, announced today that Jade Cusick, Chief Commercial Officer, has been named one of 2021s Most Inspiring Leaders in Life Sciences by PharmaVOICE.

Key Points: 
  • Kantar Health, a leader in research, data and consulting for the life sciences industry and recently acquired by the Cerner Corporation on April 1, 2021, announced today that Jade Cusick, Chief Commercial Officer, has been named one of 2021s Most Inspiring Leaders in Life Sciences by PharmaVOICE.
  • Jade is recognized for his vision and commitment to people and meaningful relationships, both internally with colleagues and externally with clients.
  • He inspires individuals to be successful in their careers at Kantar Health and has created a global and collaborative business development team.
  • Kantar Health provides data, analytics and research to the life sciences industry.

PM360 Recognizes Kantar Health’s Jeremy Brody as 2021 ELITE Winner in Transformational Leaders Category

Retrieved on: 
Friday, May 14, 2021

After forming a dedicated innovation and strategy team, he led the launch of Claritis\xe2\x84\xa2, an award-winning RWE data breakthrough approach to real world data analytics.

Key Points: 
  • After forming a dedicated innovation and strategy team, he led the launch of Claritis\xe2\x84\xa2, an award-winning RWE data breakthrough approach to real world data analytics.
  • \xe2\x80\x9cI am grateful to PM360 for this recognition, and as always, grateful to work with such an amazing group of people at Kantar Health,\xe2\x80\x9d said Jeremy Brody, Chief Strategy Officer, Kantar Health.
  • \xe2\x80\x9cThis recognition would not be possible without their contributions, so I think of this as an honor for the Kantar Health team as a whole.\xe2\x80\x9d\nThe 2021 PM360 Elite Awards recognizes the most influential people in the healthcare industry - true catalysts who are creating extraordinary results.
  • As real-world evidence and commercialization partners, Kantar Health enables clients to bring safe and effective treatment to patients around the world.